Tag: pharmaceutical patents

First-Mover Advantage: Benefits for First Generic Manufacturers

Explore the first-mover advantage for generic manufacturers under the Hatch-Waxman Act. Learn how 180-day exclusivity, path dependency, and authorized generics impact market share and revenue in the pharmaceutical industry.

Details

Patent Exclusivity vs Market Exclusivity: What’s the Real Difference in Drug Protection?

Patent exclusivity and market exclusivity are two different legal tools that protect new drugs. One comes from the patent office, the other from the FDA. Understanding the difference affects drug prices, generic competition, and how long you wait for affordable medicines.

Details